Suchergebnisse - "Bi, Yanyu"

PubPharm (24)

1

Application of combined preparation for regulating intestinal microecology to preparation of medicine for enhancing oncolytic virus immunotherapy effect

enthalten in: Europäisches Patentamt | 2023

von JIANG CHUNPING | WU JUNHUA | GUO CILIANG | +8

2

Application of combined preparation for regulating intestinal microecology to preparation of medicine for enhancing oncolytic virus immunotherapy effect

enthalten in: Europäisches Patentamt | 2023

von JIANG CHUNPING | WU JUNHUA | GUO CILIANG | +8

3

Application of microbial inoculum in preparation of preparation for enhancing curative effect of oncolytic virus

enthalten in: Europäisches Patentamt | 2023

von JIANG CHUNPING | WU JUNHUA | GUO CILIANG | +8

4

A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinoma

enthalten in: Scientific reports | 2023

von Ma, D. | Liu, S. | He, Q. | +7

5

ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Hou, G. | Lu, Z. | Bi, Y. | +2

6

ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma

enthalten in: Medical oncology | 2022

von Hou, G. | Lu, Z. | Bi, Y. | +2

7

ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma

enthalten in: Medical oncology | 2022

von Hou, G. | Lu, Z. | Bi, Y. | +2

8

ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma

enthalten in: Medical oncology | 2022

von Hou, G. | Lu, Z. | Bi, Y. | +2

9

Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy

enthalten in: Journal of cancer research and clinical oncology | 2021

von Bi, Y. | Jiang, Y. | Li, X. | +2

10

Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy

enthalten in: Journal of cancer research and clinical oncology | 2020

von Bi, Y. | Jiang, Y. | Li, X. | +2